Lifespan reports Q4 $46M loss, sustaining 2022 decline

Providence, R.I.-based Lifespan reported multimillion dollar losses both for the fourth quarter and full year amid a familiar litany of labor and supply shortages as well as investment losses.

Advertisement

While the group’s fourth quarter ending Sept. 30 saw a net overall loss of $45.6 million, the equivalent loss for the year totaled $187.6 million. Those figures compare with $11.4 million and $161.6 million gains in 2021 for the equivalent quarter and full year, respectively.

Total operating expenses increased almost 5 percent, or $33.1 million, in the fourth quarter compared to the same period in 2021, due primarily to increases in compensation and benefits of $32.4 million, Lifespan said.

In addition to labor and supply pressures, Lifespan also lost money on investments, reporting $31.2 million and $104.6 million losses for the quarter and year, respectively, compared with gains in 2021 of $1.2 million in the fourth quarter and $88.7 million for the year.

The Rhode Island health system is in crisis due to such sustained financial pressures, Lifespan CFO David Kirshner warned in September. Last month, the hospital group, which operates seven hospitals in the state plus multiple other locations, hired a new CEO and president, John Fernandez.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.